High materiality8/10
Barclays Upgrades Oscar Health Inc (OSCR) to Overweight, 'we see a visible path to an undemanding 13–15x P/E valuation'
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Target $35; price $27.22; firm Barclays; analyst Andrew Mok.
- Target $35; Price $27.22; Firm Barclays; Analyst Andrew Mok.
Key facts
- 01
Target: $35
- 02
Posted price: $27.22
- 03
Analyst firm: Barclays
- 04
Analyst: Andrew Mok
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.